Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis

Giant cell hepatitis (GCH) is commonly reported in neonatal and infantile liver diseases but rarely in adults where the term postinfantile GCH (PIGCH) is used. PIGCH is associated with many diseases, including drugs toxicity, viruses, and autoimmune liver diseases, with autoimmune hepatitis (AIH) be...

Full description

Saved in:
Bibliographic Details
Main Authors: Pinelopi Arvaniti, Kalliopi Zachou, George K. Koukoulis, George N. Dalekos
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Hepatology
Online Access:http://dx.doi.org/10.1155/2018/9793868
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556923721875456
author Pinelopi Arvaniti
Kalliopi Zachou
George K. Koukoulis
George N. Dalekos
author_facet Pinelopi Arvaniti
Kalliopi Zachou
George K. Koukoulis
George N. Dalekos
author_sort Pinelopi Arvaniti
collection DOAJ
description Giant cell hepatitis (GCH) is commonly reported in neonatal and infantile liver diseases but rarely in adults where the term postinfantile GCH (PIGCH) is used. PIGCH is associated with many diseases, including drugs toxicity, viruses, and autoimmune liver diseases, with autoimmune hepatitis (AIH) being the most prevalent. We present a case of PIGCH in a 76-year-old female without known history of liver disease who suffered from an acute severe episode of hepatitis. After careful exclusion of other hepatitis causes by imaging, virological, immunological, and microbiological investigations, a diagnosis of acute severe AIH (AS-AIH) was established. The patient was started on corticosteroids but she did not respond and died 3 days later because of advanced acute liver failure. Postmortem liver biopsy showed typical PIGCH lesions. Physicians must keep this catastrophic entity in mind in cases of unexplained acute liver injury as, contrary to our case, prompt rescue therapy with corticosteroids may be life-saving.
format Article
id doaj-art-e9fce7049a9d456785f6326f8484c011
institution Kabale University
issn 2090-6587
2090-6595
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Hepatology
spelling doaj-art-e9fce7049a9d456785f6326f8484c0112025-02-03T05:44:10ZengWileyCase Reports in Hepatology2090-65872090-65952018-01-01201810.1155/2018/97938689793868Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary MyelofibrosisPinelopi Arvaniti0Kalliopi Zachou1George K. Koukoulis2George N. Dalekos3Department of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, GreeceDepartment of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, GreeceDepartment of Pathology, Medical School, University of Thessaly, Larissa, GreeceDepartment of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, GreeceGiant cell hepatitis (GCH) is commonly reported in neonatal and infantile liver diseases but rarely in adults where the term postinfantile GCH (PIGCH) is used. PIGCH is associated with many diseases, including drugs toxicity, viruses, and autoimmune liver diseases, with autoimmune hepatitis (AIH) being the most prevalent. We present a case of PIGCH in a 76-year-old female without known history of liver disease who suffered from an acute severe episode of hepatitis. After careful exclusion of other hepatitis causes by imaging, virological, immunological, and microbiological investigations, a diagnosis of acute severe AIH (AS-AIH) was established. The patient was started on corticosteroids but she did not respond and died 3 days later because of advanced acute liver failure. Postmortem liver biopsy showed typical PIGCH lesions. Physicians must keep this catastrophic entity in mind in cases of unexplained acute liver injury as, contrary to our case, prompt rescue therapy with corticosteroids may be life-saving.http://dx.doi.org/10.1155/2018/9793868
spellingShingle Pinelopi Arvaniti
Kalliopi Zachou
George K. Koukoulis
George N. Dalekos
Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
Case Reports in Hepatology
title Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
title_full Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
title_fullStr Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
title_full_unstemmed Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
title_short Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
title_sort postinfantile giant cell hepatitis with features of acute severe autoimmune hepatitis probably triggered by diclofenac in a patient with primary myelofibrosis
url http://dx.doi.org/10.1155/2018/9793868
work_keys_str_mv AT pinelopiarvaniti postinfantilegiantcellhepatitiswithfeaturesofacutesevereautoimmunehepatitisprobablytriggeredbydiclofenacinapatientwithprimarymyelofibrosis
AT kalliopizachou postinfantilegiantcellhepatitiswithfeaturesofacutesevereautoimmunehepatitisprobablytriggeredbydiclofenacinapatientwithprimarymyelofibrosis
AT georgekkoukoulis postinfantilegiantcellhepatitiswithfeaturesofacutesevereautoimmunehepatitisprobablytriggeredbydiclofenacinapatientwithprimarymyelofibrosis
AT georgendalekos postinfantilegiantcellhepatitiswithfeaturesofacutesevereautoimmunehepatitisprobablytriggeredbydiclofenacinapatientwithprimarymyelofibrosis